Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IMUNON-INC-35726170/news/Memorial-Sloan-Kettering-Cancer-Center-Now-Enrolling-Patients-in-Phase-1-2-Clinical-Trial-of-IMUNON-46038944/?utm_source=whatsapp&utm_medium=social&utm_campaign=share